The Lancet. Respiratory medicine
Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data.
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.
Mesenchymal stem (stromal) cells for treatment of acute respiratory distress syndrome - authors' reply.
Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.
Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.
Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT.
Treating ARDS: new hope for a tough problem.
